Paper39154013
Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.
Liu D and 8 others. Cancer Cell Int, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer. Papers, record 39154013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39154013
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Telomerase related molecular subtype and risk model reveal immune activity and evaluate prognosis and immunotherapy response in prostate cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34936729 | Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/34936729 | PubMed |
| 2 | 31355524 | The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer. | Cancer Med | 2019 | https://conductscience.org/library/papers/31355524 | PubMed |
| 3 | 32457745 | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies. | Front Immunol | 2020 | https://conductscience.org/library/papers/32457745 | PubMed |
| 4 | 29799499 | KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29799499 | PubMed |
| 5 | 23876621 | Telomerase at the intersection of cancer and aging. | Trends Genet | 2013 | https://conductscience.org/library/papers/23876621 | PubMed |
| 6 | 36080493 | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches. | Molecules | 2022 | https://conductscience.org/library/papers/36080493 | PubMed |
| 7 | 28052254 | Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. | Cell Rep | 2017 | https://conductscience.org/library/papers/28052254 | PubMed |
| 8 | 25691825 | The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. | Contemp Oncol (Pozn) | 2015 | https://conductscience.org/library/papers/25691825 | PubMed |
| 9 | 34987184 | SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer. | Cell Death Differ | 2022 | https://conductscience.org/library/papers/34987184 | PubMed |
| 10 | 33754039 | FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts. | Theranostics | 2021 | https://conductscience.org/library/papers/33754039 | PubMed |
| 11 | 35860239 | Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. | Front Immunol | 2022 | https://conductscience.org/library/papers/35860239 | PubMed |
| 12 | 35975690 | TP53 loss-of-function causes vulnerability to autophagy inhibition in aggressive prostate cancer. | Int J Urol | 2022 | https://conductscience.org/library/papers/35975690 | PubMed |
| 13 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 14 | 24879116 | Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma. | Blood Cancer J | 2014 | https://conductscience.org/library/papers/24879116 | PubMed |
| 15 | 32281273 | Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32281273 | PubMed |
| 16 | 27692812 | Predicting Time From Metastasis to Overall Survival in Castration-Resistant Prostate Cancer: Results From SEARCH. | Clin Genitourin Cancer | 2017 | https://conductscience.org/library/papers/27692812 | PubMed |
| 17 | 34370973 | Prostate cancer. | Lancet | 2021 | https://conductscience.org/library/papers/34370973 | PubMed |
| 18 | 33446323 | The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer. | Urol Clin North Am | 2020 | https://conductscience.org/library/papers/33446323 | PubMed |
| 19 | 21417995 | Telomerase: structure, functions, and activity regulation. | Biochemistry (Mosc) | 2010 | https://conductscience.org/library/papers/21417995 | PubMed |
| 20 | 24979481 | Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24979481 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41882722 | In-silico study of machine learning discovers de novo lipogenesis for predicting prognosis and immunotherapy responses in kidney renal clear cell carcinoma. | Biol Direct | 2026 | https://conductscience.org/library/papers/41882722 | PubMed |
| 40299459 | Investigating the Prognostic Role of Telomerase-Related Cellular Senescence Gene Signatures in Breast Cancer Using Machine Learning. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299459 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ZW10 | 9183 | PubTator's text mining | https://conductscience.org/library/genes/9183 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39154013
GET https://conductscience.org/api/papers/v1/39154013/references?page=2